40 /100
MEDIUM RISK
Score updated May 30, 2026

SNSE — Sensei Biotherapeutics, Inc. Dilution Risk Tracker

Track SNSE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SNSE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
90
💰 Cash Runway
10
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
26%
📉 Score Deterioration 40%
• Score rose 18 points recently (worsening)
💰 Capital Raise 20%
• Active shelf registration ($200M, 705% of market cap)
🔔 Track SNSE — Get forecast alerts →

💹 Market Data

Market Cap$28.37M
Shares Outstanding1.34M
Float811.9K
Cash$202.79M
Debt$1.04M
Short InterestN/A

🏛 Institutional Holdings

99.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track SNSE for full holder detail →

📉 Short Interest

Short Interest815.5K
Days to Cover28.4
% of Float100.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2021
S-3 SHELF Apr 28, 2026
8-K 8K EVENT Apr 16, 2026
4 INSIDER TRANSACTION Apr 14, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track SNSE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SNSE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for SNSE
📊 SNSE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SNSE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.